Harding Loevner’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.2M | Sell |
168,707
-43,132
| -20% | -$16M | 0.61% | 44 |
|
|
2026
Q1 | $62M | Sell |
211,839
-8,886
| -4% | -$2.92M | 0.64% | 51 |
|
|
2025
Q4 | $77.4M | Sell |
220,725
-25,640
| -10% | -$8.66M | 0.68% | 46 |
|
|
2025
Q3 | $79.6M | Buy |
+246,365
| New | +$76.6M | 0.58% | 49 |
|
|
2020
Q3 | – | Sell |
-800
| Closed | -$210K | – | 182 |
|
|
2020
Q2 | $210K | Hold |
800
| – | – | ﹤0.01% | 79 |
|
|
2020
Q1 | $182K | Hold |
800
| – | – | ﹤0.01% | 86 |
|
|
2019
Q4 | $242K | Hold |
800
| – | – | ﹤0.01% | 85 |
|
|
2019
Q3 | $192K | Hold |
800
| – | – | ﹤0.01% | 78 |
|
|
2019
Q2 | $226K | Hold |
800
| – | – | ﹤0.01% | 81 |
|
|
2019
Q1 | $230K | Hold |
800
| – | – | ﹤0.01% | 76 |
|
|
2018
Q4 | $210K | Hold |
800
| – | – | ﹤0.01% | 77 |
|
|
2018
Q3 | $219K | Hold |
800
| – | – | ﹤0.01% | 75 |
|
|
2018
Q2 | $190K | Hold |
800
| – | – | ﹤0.01% | 74 |
|
|
2018
Q1 | $176K | Hold |
800
| – | – | ﹤0.01% | 77 |
|
|
2017
Q4 | $180K | Hold |
800
| – | – | ﹤0.01% | 75 |
|
|
2017
Q3 | $152K | Hold |
800
| – | – | ﹤0.01% | 77 |
|
|
2017
Q2 | $151K | Buy |
+800
| New | +$144K | ﹤0.01% | 72 |
|
|
2016
Q4 | – | Sell |
-800
| Closed | -$100K | – | 82 |
|
|
2016
Q3 | $100K | Hold |
800
| – | – | ﹤0.01% | 75 |
|
|
2016
Q2 | $105K | Hold |
800
| – | – | ﹤0.01% | 71 |
|
|
2016
Q1 | $111K | Hold |
800
| – | – | ﹤0.01% | 72 |
|
|
2015
Q4 | $112K | Hold |
800
| – | – | ﹤0.01% | 82 |
|
|
2015
Q3 | $112K | Hold |
800
| – | – | ﹤0.01% | 79 |
|
|
2015
Q2 | $131K | Buy |
+800
| New | +$128K | ﹤0.01% | 79 |
|
|
2015
Q1 | – | Sell |
-800
| Closed | -$101K | – | 83 |
|
|
2014
Q4 | $101K | Hold |
800
| – | – | ﹤0.01% | 84 |
|
|
2014
Q3 | $96K | Hold |
800
| – | – | ﹤0.01% | 80 |
|
|
2014
Q2 | $86K | Hold |
800
| – | – | ﹤0.01% | 79 |
|
|
2014
Q1 | $80K | Buy |
+800
| New | +$72.4K | ﹤0.01% | 82 |
|
|
2013
Q4 | – | Sell |
-800
| Closed | -$67K | – | 84 |
|
|
2013
Q3 | $67K | Hold |
800
| – | – | ﹤0.01% | 83 |
|
|
2013
Q2 | $65K | Buy |
+800
| New | +$59.9K | ﹤0.01% | 82 |
|
Other funds holding ELV
Harding Loevner's ELV Position: Q2 2026 in Review
Harding Loevner reduced its Elevance Health (ELV) stake by 20% in Q2 2026, selling an estimated $16M and leaving 168,707 shares worth $65.2M. The position accounts for 0.61% of the portfolio, ranked #44.
Harding Loevner first reported a position in ELV in Q2 2013 and has held it in 29 quarters since. The position peaked at $79.6M in Q3 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Harding Loevner held 168,707 shares of Elevance Health worth $65.2M as of Q2 2026.
- Harding Loevner sold 43,132 Elevance Health shares in Q2 2026, an estimated $16M.
- Elevance Health made up 0.61% of Harding Loevner's portfolio in Q2 2026, its #44 holding.
- Harding Loevner first reported a position in Elevance Health in Q2 2013 and has held it in 29 quarters since.
- Harding Loevner's Elevance Health position peaked at $79.6M in Q3 2025.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Harding Loevner's 13F filing for Q2 2026, filed 14 Aug 2026.